Sunday, January 18, 2026

Latest

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

NexGen Launches 42,000 Metre Drill Program At PCE While Expanding Mineralized Footprint

First Majestic Hits 2025 Guidance, Producing 31.1 Million Silver Equivalent Ounces, Increases Dividend

Related News

Democratic-Led House Committee Voted To Disclose Donald Trump’s Tax Returns

For the first time, the public gets a chance to see the tax returns of...

Wednesday, December 21, 2022, 06:25:00 AM

Trump SPAC DWAC To Take on Big Tech

“D – Wack. The DWAC SPAC. It’s a SPAC folks. But it’s temporary. It’s only...

Thursday, October 28, 2021, 01:30:00 PM

Trump Signs Order to Move Cannabis to Schedule III

President Donald Trump signed an executive order Thursday to push marijuana from Schedule I toward...

Friday, December 19, 2025, 03:02:00 PM

China Confident in Economic Resilience Despite US Tariff Pressure

Chinese officials dismissed concerns about US tariffs this week, asserting they have ample tools to...

Saturday, May 3, 2025, 09:31:00 AM

FBI Probes Leaked Iran Damage Report as Trump Disputes Findings

It appears Defense Secretary Pete Hegseth now hates leaks. On Wednesday, he said the FBI...

Thursday, June 26, 2025, 11:35:00 AM